Table 2.
Unadjusted Temporomandibular Joint Dysfunction Outcomes at Baseline, End of Treatment, and 3-Month Follow-up by Treatment Group (Mean ± Standard Deviation)
| Group | Specialty care | Traditional Chinese Medicine | Naturopathic medicine | pb | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Timea | BL | BS | ET | ET +3 | BL | BS | ET | ET +3 | BL | BS | ET | ET +3 | |
| N | 60 | 50 | 50 | 49 | 50 | 42 | 42 | 40 | 50 | 36 | 36 | 34 | |
| Worst FP | 7.6 ± 2.2 | 7.8 ± 1.8 | 6.6 ± 2.0 | 6.1 ± 2.1 | 7.5 ± 2.8 | 7.6 ± 2.9 | 5.4 ± 2.7 | 5.1 ± 3.0 | 8.2 ± 2.2 | 8.2 ± 2.3 | 5.9 ± 2.5 | 5.0 ± 2.7 | ≤0.04 (A) |
| Avg FP | 5.4 ± 2.5 | 5.5 ± 2.3 | 4.6 ± 2.0 | 4.0 ± 1.8 | 5.6 ± 2.5 | 5.5 ± 2.6 | 3.6 ± 2.1 | 3.2 ± 2.1 | 5.7 ± 2.4 | 5.8 ± 2.7 | 4.2 ± 2.5 | 3.5 ± 2.4 | ≤0.02 (B) |
| Impact on social life | 3.0 ± 3.0 | 2.9 ± 2.9 | 2.4 ± 2.2 | 2.0 ± 1.8 | 3.2 ± 3.0 | 3.0 ± 2.9 | 2.4 ± 2.4 | 2.0 ± 2.2 | 3.7 ± 2.6 | 3.7 ± 2.6 | 2.5 ± 2.1 | 1.9 ± 2.2 | ≤0.02(C) |
BL, baseline for everyone; BS, baseline for those who had treatments and outcomes and were included in analyses; ET, end of treatment; ET+3, 3 months post ET; FP, facial pain.
Minimum significance level of bolded treatment intervention improvement compared to improvement in specialty care group; details provided below.
A: ET v. BS: T-S p = 0.010, N-S p = 0.025, N-T p = 0.840; ET+3 v. BS: T-S p = 0.037, N-S p = 0.019; N-T p = 0.725.
B: ET v. BS: T-S p = 0.004, N-S p = 0.145; N-T p = 0.225; ET+3 v. BS: T-S p = 0.017, N-S p = 0.118; N-T p = 0.495.
C: ET v. BS: T-S p = 0.758, N-S p = 0.012; N-T p = 0.034; ET+3 v. BS: T-S p = 0.927, N-S p = 0.099; N-T p = 0.099.